Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma

Clinical Science

Volumn 90, Issue 2, 1996, Pages 127-133

  Chow, Nan Haw ^a,b   Chang, Chih Jen ^a   Yeh, Trai Ming ^a   Chan, Shih Huang ^a   Tzai, Tzong Shin ^a   Lin, Johnny Shinn Nan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Host tumour interaction; Inflammation; Transitional cell carcinoma; Urological disease

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CREATININE; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; URINARY EXCRETION; UROGENITAL TRACT CANCER;

EID: 0030044953     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900127     Document Type: Article

References (36)

1. Folkman J. Tumor angiogenesis factor. Cancer Res 1974; 34: 2109-13.
2. Stafl A, Mattomgly RF. Angiogenesis of cervical neoplasia. Am J Obstet Gynecol 1975; 121: 845-52.
3. Smith-Mccune KK, Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994; 54: 800-4.
4. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
5. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993; 55: 371-4.
6. Yamazaki K, Abe S, Takekaea H, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994; 74: 2245-50.
7. Folkman J, Klagsbrun M. Angiogenic factors. Science (Washington DC) 1987; 235: 442-7.
8. Folkman J, Merlet E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275-88.
9. Shahabuddin S, Arnold F, Costello B, Kumar S. Tumor angiogenesis factor in urological cancers. Br J Urol 1984; 56: 490-4.
10. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H, Sasse J. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 1988; 48: 2083-8.
11. Nguyen M, Watanabe H, Budson AE, Richie JP, Folkman J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 1993; 85: 241-2.
12. Hughes SE, Hall PA. Immunolocalization of fibroblast growth factor receptor I and its ligands in human tissues. Lab Invest 1993; 69: 173-82.
13. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of the angiogenic peptide basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994; 86: 356-61.
14. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H. Immunohistochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993; 68: 520-7.
15. Emoto N, Isozaki O, Ohmura E, et al. Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth. J Urol 1994; 152: 1626-31.
16. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993; 53: 5289-96.
17. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (≤1.0 mm) are associated with angiogenesis. Am J Pathol 1993; 143: 99-104.
18. Weidner N, Semple J, Welch W, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
19. Wakui S, Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1993; 168: 257-62.
20. Chopin D, Caruelle JP, Colombel M, et al. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol 1993; 150: 1126-30.
21. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GNA, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994; 74: 762-6.
22. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition of hyperplasia to neoplasia. Nature (London) 1989; 339: 58-61.
23. Kandel J, Bossy-Wetzel E, Radvanyi F, Klabsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991; 66: 1095-104.
24. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995; 55: 510-13.
25. Brem S, Ana Maria CT, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 1992; 70: 2673-80.
26. Nanus DM, Schmitz-Drager BJ, Motzer RJ, et al. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 1993; 85: 1597-9.
27. Mcneil PL, Muthukrishman L, Warder E, D'Amore PA. Growth factors are released by mechanically wounded cells. J Cell Biol 1989; 109: 811-22.
28. Soutter AD, Nguyen M, Watanabe H, Folkman J. Basic fibroblast growth factor secreted by animal tumor is detectable in urine. Cancer Res 1993; 53: 5297-9.
29. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am J Pathol 1988; 130: 393-400.
30. Cordon-cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990; 63: 832-40.
31. Gorelik U, Lindner A, Mayer M. Protease and plasminogen activator activity in human bladder carcinoma. Br J Urol 1990; 66: 170-4.
32. Weiss RE, Liu CS, Ahlering T, Dubeau L, Droller MJ. Mechanisms of human bladder tumor invasion: role of protease cathepsin. Br J Urol 1990; 144: 798-804.
33. Saksela O, Rifkin OB. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110: 767-75.
34. Falcone DJ, Mccaffrey TA, Hamovitz-Friedman A, Vergilio JA, Nicholson AC. Macrophages and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem 1993; 268: 11951-8.
35. + T cells. Proc Natl Acad Sci USA 1994; 91: 2890-4.
36. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 1994; 86: 1303-14.